M. ARSLAN Et Al. , "Can FDG PET/CT and CT Exclude N2 and N3 Nodal Disease in Patients with Breast Cancer?," Journal of Clinical Experimental Oncology , vol.7, no.1, pp.1-5, 2018
ARSLAN, M. Et Al. 2018. Can FDG PET/CT and CT Exclude N2 and N3 Nodal Disease in Patients with Breast Cancer?. Journal of Clinical Experimental Oncology , vol.7, no.1 , 1-5.
ARSLAN, M., GULEK, B., POLAT KELLE, A., AKBULUT, S., UĞURLU, E., GÜNEY, İ. B., ... SÖZÜTOK, S.(2018). Can FDG PET/CT and CT Exclude N2 and N3 Nodal Disease in Patients with Breast Cancer?. Journal of Clinical Experimental Oncology , vol.7, no.1, 1-5.
ARSLAN, MUHAMMET Et Al. "Can FDG PET/CT and CT Exclude N2 and N3 Nodal Disease in Patients with Breast Cancer?," Journal of Clinical Experimental Oncology , vol.7, no.1, 1-5, 2018
ARSLAN, MUHAMMET Et Al. "Can FDG PET/CT and CT Exclude N2 and N3 Nodal Disease in Patients with Breast Cancer?." Journal of Clinical Experimental Oncology , vol.7, no.1, pp.1-5, 2018
ARSLAN, M. Et Al. (2018) . "Can FDG PET/CT and CT Exclude N2 and N3 Nodal Disease in Patients with Breast Cancer?." Journal of Clinical Experimental Oncology , vol.7, no.1, pp.1-5.
@article{article, author={MUHAMMET ARSLAN Et Al. }, title={Can FDG PET/CT and CT Exclude N2 and N3 Nodal Disease in Patients with Breast Cancer?}, journal={Journal of Clinical Experimental Oncology}, year=2018, pages={1-5} }